| II-53 Valerie Cosson Amyloid related imaging abnormalities (ARIA): Time to event modeling to identify new Phase 3 doses and dosing regimens for Gantenerumab Wednesday 15:10-16:30 |
| II-53 Valerie Cosson Amyloid related imaging abnormalities (ARIA): Time to event modeling to identify new Phase 3 doses and dosing regimens for Gantenerumab Wednesday 15:10-16:30 |